SEM1P1: A Potential Drug Target Or Biomarker for Various Diseases

Target Name: SEM1P1

NCBI ID: G153842

SEM1P1

Other Name(s): SHFM1P1 | DSS1P1 | SEM1 pseudogene 1 | SHFM1P

SEM1P1: A Potential Drug Target Or Biomarker for Various Diseases

SEM1P1 (SHFM1P1) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 10 and encodes a protein known as SEM1P1.

SEM1P1 is a transmembrane protein that plays a role in the regulation of cell signaling pathways, specifically the TGF-β pathway. This pathway is involved in the development and maintenance of tissues and organs, as well as in the regulation of cell growth and differentiation. SEM1P1 is a key regulator of TGF-β activity, and studies have shown that it plays a critical role in the regulation of cell proliferation and survival.

In addition to its role in TGF-β signaling, SEM1P1 has also been shown to be involved in the regulation of other signaling pathways, including the PI3K/Akt signaling pathway. This pathway is involved in the regulation of cell survival and proliferation, and has been implicated in the development of various diseases, including cancer.

SEM1P1 has also been shown to be involved in the regulation of cell adhesion and migration. This is important for the development and maintenance of tissues and organs, and is also implicated in the development of various diseases, including cancer.

In conclusion, SEM1P1 is a gene that has the potential to be a drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand its role in the regulation of cell signaling pathways and its potential as a therapeutic target.

Protein Name: SEM1 Pseudogene 1

The "SEM1P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEM1P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets